Literature DB >> 22130538

Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells.

Kathryn Austgen1, Scott A Oakes, Don Ganem.   

Abstract

The development of a mouse model for Kaposi's sarcoma-associated herpesvirus (KSHV) infection has been impeded by the limited host range of the virus. Here, we have examined the molecular basis of this host range restriction. KSHV efficiently enters murine cells and establishes latency. However, ectopic expression of the lytic switch protein RTA (replication and transcription activator) in these cells induces little viral gene expression and no virus production. Upon treatment with histone deacetylase inhibitors, KSHV-infected murine cells display more extensive but aberrant viral transcription and do not support either viral DNA synthesis or the production of infectious virions. These aberrantly infected cells also display markedly enhanced apoptosis. Genetic ablation of the mitochondrial apoptotic pathway in these cells prolongs their survival and permits viral DNA replication but does not rescue the generation of virions. We conclude that multiple defects, both prior to and following DNA synthesis, restrict lytic KSHV infection in murine cells.

Entities:  

Mesh:

Year:  2011        PMID: 22130538      PMCID: PMC3264352          DOI: 10.1128/JVI.06600-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  Jill T Bechtel; Yuying Liang; Joshua Hvidding; Don Ganem
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells.

Authors:  Mark L Cannon; Ethels Cesarman
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

3.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

4.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

5.  Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Authors:  Yuying Liang; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

6.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

7.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Jeffrey Vieira; Patricia M O'Hearn
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

8.  RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.

Authors:  Yuying Liang; Don Ganem
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

10.  The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

Authors:  T Lindsten; A J Ross; A King; W X Zong; J C Rathmell; H A Shiels; E Ulrich; K G Waymire; P Mahar; K Frauwirth; Y Chen; M Wei; V M Eng; D M Adelman; M C Simon; A Ma; J A Golden; G Evan; S J Korsmeyer; G R MacGregor; C B Thompson
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

View more
  14 in total

Review 1.  The role of endoplasmic reticulum stress in human pathology.

Authors:  Scott A Oakes; Feroz R Papa
Journal:  Annu Rev Pathol       Date:  2014-10-27       Impact factor: 23.472

2.  A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.

Authors:  Henry H Chang; Don Ganem
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

3.  Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Lin-Xu Wang; Guobin Kang; Pankaj Kumar; Wuxun Lu; Yue Li; You Zhou; Qingsheng Li; Charles Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

4.  Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.

Authors:  Xiaohong Kong; Dongmei Li; Amirsalar Mansouri; Guobin Kang; Khalid Sayood; John West; Charles Wood
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

5.  Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice.

Authors:  Junjie Zhang; Lining Zhu; Xiaolu Lu; Emily R Feldman; Lisa R Keyes; Yi Wang; Hui Fan; Hao Feng; Zanxian Xia; Jiya Sun; Taijiao Jiang; Shou-Jiang Gao; Scott A Tibbetts; Pinghui Feng
Journal:  PLoS Pathog       Date:  2015-06-24       Impact factor: 6.823

6.  Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication.

Authors:  Brittany M Ashlock; Qi Ma; Biju Issac; Enrique A Mesri
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

7.  Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis.

Authors:  P Chudasama; A Konrad; R Jochmann; B Lausen; P Holz; E Naschberger; F Neipel; N Britzen-Laurent; M Stürzl
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

8.  Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines.

Authors:  Barbara A Scholz; Marie L Harth-Hertle; Georg Malterer; Juergen Haas; Joachim Ellwart; Thomas F Schulz; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

9.  The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors.

Authors:  Rachel Yamin; Noa S Kaynan; Ariella Glasner; Alon Vitenshtein; Pinchas Tsukerman; Yoav Bauman; Yael Ophir; Shlomo Elias; Yotam Bar-On; Chamutal Gur; Ofer Mandelboim
Journal:  PLoS Pathog       Date:  2013-08-15       Impact factor: 6.823

10.  Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells.

Authors:  Sydney Simpson; Guillaume Fiches; Maxime J Jean; Michael Dieringer; James McGuinness; Sinu P John; Meir Shamay; Prashant Desai; Jian Zhu; Netty G Santoso
Journal:  Front Microbiol       Date:  2018-04-24       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.